{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:12:11Z","timestamp":1791994331661,"version":"4.4.0"},"reference-count":58,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:sec id=\"ab-doi250071-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Cutaneous squamous cell carcinoma (cSCC), cSCC in situ (CIS), and keratoacanthoma (KA) pose growing public health challenges, due to their associated morbidity, health care burden and costs. However, many countries lack systematic registration of these extremely frequent keratinocyte neoplasms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi250071-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To estimate incidence rates and trends of first-time, histologically confirmed cSCC, CIS, and KA in Denmark (2005-2023) by sex, age, and anatomical site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi250071-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>A nationwide, population-based study using data from the Danish Pathology Registry and Cancer Registry was conducted, including individuals 20 years or older receiving a first-time diagnosis of cSCC, CIS, or KA from January 1, 2005 to December 31, 2023. Data analyses were conducted from January to July 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi250071-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Age-standardized incidence rates (ASIRs) as well as age-specific incidence rates per 100\u202f000 person-years with corresponding estimated annual percentage changes (EAPCs) and 95% CIs were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi250071-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 109\u202f787 histologically confirmed cases were identified in 95\u202f352 unique individuals (55\u202f891 male individuals [50.9%], 53\u202f896 female individuals [49.1%]) 20 years or older in Denmark, receiving a first-time diagnosis of cSCC (n\u2009=\u200954\u202f563), CIS (n\u2009=\u200931\u202f712), or KA (n\u2009=\u200923\u202f512). From 2005 to 2023, cSCC ASIRs increased (EAPC for male individuals, 2.6%; EAPC for female individuals, 3.1%), reaching 131.6 and 77.7 per 100\u202f000 person-years in male individuals and female individuals, respectively. CIS increased markedly (EAPC, for male individuals, 6.4%; EAPC for female individuals, 5.8%), and KA declined. Stratified analyses showed distinct sex-specific anatomic patterns. Predilection sites for cSCC and CIS were the face, scalp, and neck, with particular predominance among male individuals. Female individuals exhibited higher ASIRs on the lower limbs compared with male individuals (male vs female individuals: cSCC, 7.63 vs 12.32 per 100\u202f000; CIS, 6.21 vs 12.63 per 100\u202f000; KA, 3.47 vs 7.20 per 100\u202f000, respectively). KA primarily affected the extremities. Female individuals aged 40 to 59 years showed higher incidence rates than male individuals across all keratinocyte neoplasms (male vs female individuals: cSCC, 131.6 vs. 77.7 per 100\u202f000; CIS, 89.4 vs. 78.6 per 100\u202f000; KA 28.6 vs. 27.6 per 100\u202f000, respectively). Trends among individuals younger than 50 years with cSCC and KA were stable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-doi250071-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this nationwide cohort study presenting the most comprehensive dataset of incident cSCC, CIS, and KA, with 109\u202f787 histologically confirmed patient cases, covering nearly 2 decades and spanning across all Danish health care sectors, incidence of cSCC and CIS continued to rise, consequently affecting more people, and sex differences diminished. Stabilizing trends in individuals younger than 50 years may indicate early prevention effects. Findings of this study have the potential to influence future surveillance activities and clinical care through attention to sex, age, and anatomical site.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamadermatol.2025.5700","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:31:14Z","timestamp":1769617874000},"page":"333","source":"Crossref","is-referenced-by-count":6,"title":["Incidence Trends of Cutaneous Squamous Cell Carcinoma, Carcinoma In Situ, and Keratoacanthoma By Sex, Age, and Anatomical Site"],"prefix":"10.1001","volume":"162","author":[{"given":"Kirstine","family":"Duffau","sequence":"first","affiliation":[{"name":"Virus, Lifestyle and Genes, Danish Cancer Institute, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Baandrup","sequence":"additional","affiliation":[{"name":"Virus, Lifestyle and Genes, Danish Cancer Institute, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Pathology, Zealand University Hospital, Roskilde, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Frederiksen","sequence":"additional","affiliation":[{"name":"Statistics and Data Analysis, Danish Cancer Institute, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Hansen","sequence":"additional","affiliation":[{"name":"Cancer Survivorship, Danish Cancer Institute, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Jensen","sequence":"additional","affiliation":[{"name":"Virus, Lifestyle and Genes, Danish Cancer Institute, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina L.","family":"M\u00e5rtensson","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"H\u00e6dersdal","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Dermatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen NV, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne K.","family":"Kj\u00e6r","sequence":"additional","affiliation":[{"name":"Virus, Lifestyle and Genes, Danish Cancer Institute, Copenhagen, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Gynecology, Copenhagen University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"doi250071r1","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1186\/s12885-022-09940-3","article-title":"Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25?years.","volume":"22","author":"Hu","year":"2022","journal-title":"BMC Cancer"},{"issue":"10","key":"doi250071r2","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jamadermatol.2014.762","article-title":"Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships.","volume":"150","author":"Xiang","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"2","key":"doi250071r3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/bjd\/ljac064","article-title":"Trends in keratinocyte skin cancer incidence, mortality and burden of disease in 33 countries between 1990 and 2017.","volume":"188","author":"Yang","year":"2023","journal-title":"Br J Dermatol"},{"issue":"4","key":"doi250071r4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/bjd\/ljad425","article-title":"International patterns and trends in the incidence of melanoma and cutaneous squamous cell carcinoma, 1989-2020.","volume":"190","author":"Olsen","year":"2024","journal-title":"Br J Dermatol"},{"issue":"3","key":"doi250071r5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1159\/000529369","article-title":"Skin cancer development is strongly associated with actinic keratosis in solid organ transplant recipients: a Danish cohort study.","volume":"239","author":"Wenande","year":"2023","journal-title":"Dermatology"},{"key":"doi250071r6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/jdv.16025","article-title":"Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance-the impact of immunosuppression on frequency of cSCC.","volume":"33","author":"Plasmeijer","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"doi250071r7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/jdv.15846","article-title":"Comparison of guidelines for the management of patients with high-risk and advanced cutaneous squamous cell carcinoma\u2014a systematic review.","volume":"33","author":"Heppt","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"12","key":"doi250071r8","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1001\/jamadermatol.2020.3677","article-title":"Incidence of multiple vs first cutaneous squamous cell carcinoma on a nationwide scale and estimation of future incidences of cutaneous squamous cell carcinoma.","volume":"156","author":"Tokez","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"Suppl 8","key":"doi250071r9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jdv.15967","article-title":"Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents.","volume":"33","author":"Stang","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"doi250071r10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/bjd.15324","article-title":"Cutaneous squamous cell carcinoma: an epidemiological review.","volume":"177","author":"Green","year":"2017","journal-title":"Br J Dermatol"},{"issue":"3","key":"doi250071r11","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/bjd.19879","article-title":"Invasive and in situ squamous cell carcinoma of the skin: a nationwide study in Iceland.","volume":"185","author":"Adalsteinsson","year":"2021","journal-title":"Br J Dermatol"},{"issue":"2","key":"doi250071r12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/CEJ.0000000000000056","article-title":"Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.","volume":"24","author":"Gordon","year":"2015","journal-title":"Eur J Cancer Prev"},{"issue":"6","key":"doi250071r13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/CEJ.0b013e328360150c","article-title":"Costs of illness for melanoma and nonmelanoma skin cancer in Denmark.","volume":"22","author":"Bentzen","year":"2013","journal-title":"Eur J Cancer Prev"},{"issue":"6","key":"doi250071r14","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.canep.2011.05.006","article-title":"Incidence of cutaneous squamous cell carcinoma in coastal and inland areas of Western Sweden.","volume":"35","author":"Andersson","year":"2011","journal-title":"Cancer Epidemiol"},{"issue":"12","key":"doi250071r16","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1001\/jamadermatol.2020.3678","article-title":"Underestimation of cutaneous squamous cell carcinoma incidence, even in cancer registries.","volume":"156","author":"Wehner","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"doi250071r17","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer.","volume":"166","author":"Lomas","year":"2012","journal-title":"Br J Dermatol"},{"issue":"6","key":"doi250071r19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.4132\/jptm.2023.09.22","article-title":"What\u2019s new in dermatopathology 2023: WHO 5th edition updates.","volume":"57","author":"Ho","year":"2023","journal-title":"J Pathol Transl Med"},{"issue":"4","key":"doi250071r20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.32074\/1591-951X-1006","article-title":"The 2023 WHO updates on skin tumors: advances since the 2018 edition.","volume":"116","author":"Fortarezza","year":"2024","journal-title":"Pathologica"},{"issue":"7","key":"doi250071r21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1403494810393563","article-title":"The Danish Pathology Register.","volume":"39","author":"Bjerregaard","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7","key":"doi250071r22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1403494810393562","article-title":"The Danish Cancer Registry.","volume":"39","author":"Gjerstorff","year":"2011","journal-title":"Scand J Public Health"},{"issue":"7","key":"doi250071r23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/1403494810387965","article-title":"The Danish Civil Registration System.","volume":"39","author":"Pedersen","year":"2011","journal-title":"Scand J Public Health"},{"issue":"2","key":"doi250071r27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1097-0215(19981005)78:2<144::AID-IJC3>3.0.CO;2-Z","article-title":"Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect?","volume":"78","author":"Staples","year":"1998","journal-title":"Int J Cancer"},{"issue":"9","key":"doi250071r28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.5694\/mja2.52293","article-title":"Age group-specific changes in keratinocyte cancer treatment rates in Australia, 2012-2021: a retrospective cohort study based on MBS claims data.","volume":"220","author":"Olsen","year":"2024","journal-title":"Med J Aust"},{"issue":"3","key":"doi250071r29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/cancers16030606","article-title":"Epidemiology of keratinocyte skin cancer with a focus on cutaneous squamous cell carcinoma.","volume":"16","author":"Nanz","year":"2024","journal-title":"Cancers (Basel)"},{"key":"doi250071r30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-3-030-46227-7_6","article-title":"Epidemiology of skin cancer: update 2019.","volume":"1268","author":"Leiter","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"doi250071r31","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1684\/ejd.2023.4496","article-title":"The incidence of non-melanoma skin cancer in the UK and the Republic of Ireland: a systematic review.","volume":"33","author":"Ibrahim","year":"2023","journal-title":"Eur J Dermatol"},{"key":"doi250071r32","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v104.39891","article-title":"Recent changes in the incidence and characteristics of cutaneous squamous cell carcinomas in Finland from 2006 to 2020: a retrospective cohort study.","volume":"104","author":"Lounas","year":"2024","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"doi250071r33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/cam4.404","article-title":"Cutaneous squamous cell carcinoma in Norway 1963-2011: increasing incidence and stable mortality.","volume":"4","author":"Robsahm","year":"2015","journal-title":"Cancer Med"},{"key":"doi250071r34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2023.01.017","article-title":"Incidence, mortality and trends of cutaneous squamous cell carcinoma in Germany, the Netherlands, and Scotland.","volume":"183","author":"Keim","year":"2023","journal-title":"Eur J Cancer"},{"issue":"8","key":"doi250071r35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5694\/mja17.00284","article-title":"The incidence and multiplicity rates of keratinocyte cancers in Australia.","volume":"207","author":"Pandeya","year":"2017","journal-title":"Med J Aust"},{"issue":"2","key":"doi250071r36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/ajd.13830","article-title":"Defining the incidence of cutaneous squamous cell carcinoma in coastal NSW Australia.","volume":"63","author":"Wilson","year":"2022","journal-title":"Australas J Dermatol"},{"issue":"1","key":"doi250071r37","doi-asserted-by":"crossref","DOI":"10.17061\/phrp3212203","article-title":"Keratinocyte cancer incidence in Australia: a review of population-based incidence trends and estimates of lifetime risk.","volume":"32","author":"Olsen","year":"2022","journal-title":"Public Health Res Pract"},{"issue":"1475","key":"doi250071r38","first-page":"61","article-title":"Incidence, demographics and surgical outcomes of cutaneous squamous cell carcinoma diagnosed in Northland, New Zealand.","volume":"131","author":"Elliott","year":"2018","journal-title":"N Z Med J"},{"issue":"6","key":"doi250071r39","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.mayocp.2017.02.015","article-title":"Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010.","volume":"92","author":"Muzic","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"doi250071r40","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012.","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"6","key":"doi250071r41","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2012.11.037","article-title":"Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012.","volume":"68","author":"Karia","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"doi250071r42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejca.2021.04.029","article-title":"Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036.","volume":"152","author":"Garbe","year":"2021","journal-title":"Eur J Cancer"},{"issue":"8","key":"doi250071r43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022094","article-title":"Sunbed use 2007-2015 and skin cancer projections of campaign results 2007-2040 in the Danish population: repeated cross-sectional surveys.","volume":"8","author":"K\u00f8ster","year":"2018","journal-title":"BMJ Open"},{"issue":"41","key":"doi250071r44","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012738","article-title":"Development in sunburn 2007-2015 and skin cancer projections 2007-2040 of campaign results in the Danish population.","volume":"97","author":"K\u00f8ster","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"doi250071r45","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/210813","article-title":"Histopathological variants of cutaneous squamous cell carcinoma: a review.","volume":"2011","author":"Yanofsky","year":"2011","journal-title":"J Skin Cancer"},{"issue":"4","key":"doi250071r46","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/jvc2.478","article-title":"Incidence and geographic differences in keratinocyte carcinoma and Bowen\u2019s disease in office-based dermatological practice between 2013 and 2022: a nationwide Danish registry-based study.","volume":"3","author":"Sieborg","year":"2024","journal-title":"JEADV Clin Pract"},{"issue":"9","key":"doi250071r48","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jamadermatol.2020.1988","article-title":"Assessment of cutaneous squamous cell carcinoma (cSCC) In situ incidence and the risk of developing invasive cSCC in patients with prior cSCC In situ vs the general population in the Netherlands, 1989-2017.","volume":"156","author":"Tokez","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"1","key":"doi250071r49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2133.1979.tb03568.x","article-title":"Keratoacanthoma\u2013a thirty year retrospect.","volume":"100","author":"Rook","year":"1979","journal-title":"Br J Dermatol"},{"issue":"3","key":"doi250071r50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archderm.1993.01680240057005","article-title":"Keratoacanthoma in Kauai, Hawaii. The first documented incidence in a defined population.","volume":"129","author":"Chuang","year":"1993","journal-title":"Arch Dermatol"},{"issue":"2","key":"doi250071r51","first-page":"117","article-title":"Keratoacanthomas: overview and comparison between Houston and Minneapolis experiences.","volume":"9","author":"Vergilis-Kalner","year":"2010","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"doi250071r52","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jaad.2015.11.033","article-title":"Keratoacanthoma (KA): an update and review.","volume":"74","author":"Kwiek","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"doi250071r53","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bjd.20389","article-title":"A clinical and biological review of keratoacanthoma.","volume":"185","author":"Tisack","year":"2021","journal-title":"Br J Dermatol"},{"issue":"12","key":"doi250071r54","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamadermatol.2020.4097","article-title":"Assessment of incidence rate and risk factors for keratoacanthoma among residents of Queensland, Australia.","volume":"156","author":"Claeson","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"6","key":"doi250071r55","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3824","article-title":"Patient and tumour characteristics of keratoacanthoma in a large, community-based cohort study from Queensland, Australia.","volume":"101","author":"Kolmodin","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"doi250071r56","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1111\/ijd.15068","article-title":"A retrospective, cross-sectional study characterizing site-specific and laterality patterns of keratoacanthomas.","volume":"60","author":"Brody","year":"2021","journal-title":"Int J Dermatol"},{"issue":"3","key":"doi250071r57","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bjd.17873","article-title":"Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study.","volume":"181","author":"Venables","year":"2019","journal-title":"Br J Dermatol"},{"key":"doi250071r18","author":"Elder","year":"2022"},{"key":"doi250071r47","author":"LeBoit","year":"2018"},{"key":"doi250071r15","unstructured":"Surveillance, Epidemiology, and End Results Database. SEER interactive browser. Accessed October 14, 2025. https:\/\/seer.cancer.gov\/statistics\/interactive.html"},{"key":"doi250071r24","unstructured":"Patologiregisteret. New and changed SNOMED codes January 1, 2020. The Danish Patobank. Accessed June 2, 2025. https:\/\/www.patobank.dk\/wp-content\/uploads\/2020\/10\/nye-10-2020.pdf"},{"key":"doi250071r25","unstructured":"Patologiregisteret. New and changed SNOMED-codes January 4, 2020. The Danish Patobank. Accessed June 2, 2025. https:\/\/www.patobank.dk\/wp-content\/uploads\/2020\/04\/nye-04-2020.pdf"},{"key":"doi250071r26","unstructured":"European Economic Commission. Revision of the European Standard Population - Report of Eurostat\u2019s task force. 2013. Accessed April 1, 2025. https:\/\/ec.europa.eu\/eurostat\/documents\/3859598\/5926869\/KS-RA-13-028-EN.PDF"},{"key":"doi250071r58","unstructured":"Danmarks Statistik. Indvandrere i Danmark-2024. Accessed October 10, 2025. https:\/\/www.dst.dk\/Site\/Dst\/Udgivelser\/GetPubFile.aspx?id=52300&sid=indv2024"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2844462\/jamadermatology_duffau_2026_oi_250071_1775760794.49465.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T15:00:40Z","timestamp":1776265240000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2844462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2025.5700","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,1]]}}}